Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra D Pittman

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 16, 2002
Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transferJohn A Jane, Bradley A Dunford, Adam Kron, et al.
Atherosclerosis|April 2, 2008
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesisValerie Clerin, Heather H Shih, Nanhua Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
Mabs|June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and BMacy Jin, Sunita Hett, Reema Jasuja, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent mannerBenfang Helen Ruan, Xin Li, Aaron R Winkler, et al.
Shock (Augusta, Ga.)|January 26, 2011
A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumoniaEirini Christaki, Steven M Opal, James C Keith, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Blood|January 4, 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaJoão Arezes, Niall Foy, Kirsty McHugh, et al.
International Immunopharmacology|May 4, 2004
Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2Jing Li, Kathy N Tomkinson, Xiang-Yang Tan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 16, 2002
Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transferJohn A Jane, Bradley A Dunford, Adam Kron, et al.
Atherosclerosis|April 2, 2008
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesisValerie Clerin, Heather H Shih, Nanhua Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
Mabs|June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and BMacy Jin, Sunita Hett, Reema Jasuja, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent mannerBenfang Helen Ruan, Xin Li, Aaron R Winkler, et al.
Shock (Augusta, Ga.)|January 26, 2011
A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumoniaEirini Christaki, Steven M Opal, James C Keith, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Blood|January 4, 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaJoão Arezes, Niall Foy, Kirsty McHugh, et al.
International Immunopharmacology|May 4, 2004
Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2Jing Li, Kathy N Tomkinson, Xiang-Yang Tan, et al.
Pageof 4